Breaks Categories: News

MondayFeb 05, 2018 9:54 am

CannabisNewsBreaks – Hiku Brands Company Ltd. (CSE: HIKU) (OTC: DJACF) Subsidiary Approaching Pre-Sales Inspection

Canada’s first vertically-integrated cannabis brand house, Hiku Brands Company Ltd. (CSE: HIKU) (OTC: DJACF), through its DOJA Cannabis Ltd. subsidiary, this morning announced that it has received notification from Health Canada that its pre-sales inspection has been scheduled for Tuesday, February 13, 2018. Per the update, the pre-sales license inspection is the final step prior to the issuance of a sales license under the terms of the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). “As there are currently only 26 independent companies with cannabis sales licenses under the ACMPR in Canada, receiving confirmation of our Pre-Sales License Inspection from…

Continue Reading

ThursdayFeb 01, 2018 10:26 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Acquires Harvest Medicine Inc.

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has completed its acquisition of Harvest Medicine Inc. pursuant to the terms of a share purchase agreement dated January 31, 2018. Per the update, the acquisition was completed in consideration for, among other things, a cash payment of $1.5 million, the issuance of 1,056,338 common shares in the capital of the company and additional post-closing consideration related to certain performance milestones, including patient revenue and profitability metrics. Moving forward, Harvest Medicine will operate as a wholly-owned subsidiary of ABcann, but it will maintain its commitment to being an…

Continue Reading

WednesdayJan 31, 2018 2:58 pm

CannabisNewsBreaks – Organigram Holdings, Inc. (TSX.V: OGI) (OTCQB: OGRMF) Closes $115M Convertible Debenture Offering

Organigram Holdings (TSX.V: OGI) (OTCQB: OGRMF) this morning said that is has closed its short form prospectus offering of convertible unsecured debentures of the company on a bought deal basis, including the full exercise of the over-allotment option. A total of 115,000 convertible debentures were sold during the offering at a price of $1,000 each, resulting in gross proceeds of $115,000,000 to the company. Organigram intends to use the proceeds from the offering to support the strengthening of its stance within the Canadian and global cannabis markets. The securities have not been and will not be offered or sold within…

Continue Reading

TuesdayJan 30, 2018 1:50 pm

CannabisNewsBreaks – DOJA Cannabis Company (CSE: DOJA) (OTC: DJACF) Closes Merger with Tokyo Smoke, Launches Hiku Brands

DOJA Cannabis Company (CSE: DOJA) (OTC: DJACF) and Tokyo Smoke, a trademark and brand of TS Brandco Holdings, have successfully completed the previously announced merger of the two companies to create Hiku, Canada’s first retail and brand-focused licensed cannabis producer. Hiku has established a substantial national retail footprint and a growing portfolio of premium cannabis lifestyle brands including DOJA, Tokyo Smoke and Van der Pop. Common shares of Hiku are anticipated to begin trading on the Canadian Stock Exchange under the ticker symbol HIKU on January 31, 2018. To view the full press release, visit http://cnw.fm/ve5Iw About DOJA Cannabis Company…

Continue Reading

ThursdayJan 25, 2018 3:55 pm

CannabisNewsBreaks – Choom Holdings, Inc. (CSE: CHOO) (OTCQB: CHOOF) Debuts Concept of Retail Dispensary; Engages Design Team

Canadian cannabis cultivation company, Choom™ (CSE: CHOO) (OTCQB: CHOOF), recently confirmed that is has embarked on an innovative retail dispensary strategy by releasing its concept of a new retail store design. The company remains focused on engaging recreational and lifestyle brands in the legal cannabis market, and intends to be a major player reaching Canadian cannabis consumers. Choom’s retail dispensary strategy aims to exploit the burgeoning market sector in areas of Canada that permit the private distribution of recreational cannabis through developing a chain of branded retail cannabis dispensaries. In an effort to remain a step ahead of the competition,…

Continue Reading

WednesdayJan 24, 2018 3:13 pm

CannabisNewsBreaks – True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF) Secures New Equity Financing

True Leaf Medicine International (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF) this morning said it has raised C$14 million in equity financing that will enable the life cannabis company to move forward with its medicinal cannabis facility. True Leaf raised C$10M in a Regulation A+ public equity offering priced at C$0.70 per share, making it the first Canadian-listed company to successfully conduct such an offering. Additionally, the company said it is currently working toward the close of a $4,051,654.60 non-brokered private placement via the sale of 5,788,078 common shares at a price of C$0.70 per share, available to Canadian investors only.…

Continue Reading

WednesdayJan 24, 2018 2:46 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Secures $2M in Private Placement

On January 22, Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) said that it closed a non-brokered private placement financing of 5,000,000 units at a price of $0.40 each. Each unit consists of one common share and one-half of one transferable share purchase warrant. Each whole warrant entitles the holder to further purchase one common share for a period of up to twenty-four months at a price of $0.60. The company also issued 259,485 finder's units with the same entails. The company received total gross proceeds of $2,000,000 from the offering which it intends to use toward fast-tracking…

Continue Reading

ThursdayJan 18, 2018 11:09 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Subsidiary Receives Import License from Australia

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), through wholly-owned subsidiary ABcann Australia Pty Ltd., this morning announced that it has received an import license from the Federal Office of Drug Control in Australia. Following receipt of necessary approvals, including approval from the TSX Venture Exchange, ABcann intends to supply medicinal cannabis to the Australian market via the Australian Department of Health’s Therapeutic Goods Administration (“TGA”) Special Access Scheme. “This import license is a key milestone towards generating revenue through ABcann’s network of physicians, pharmacists and patients, and advancing the use of medical cannabis,” Barry Fishman, chief executive officer of ABcann,…

Continue Reading

TuesdayJan 09, 2018 11:47 am

CannabisNewsBreaks – DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) Completes $12.5 Million Private Placement

Premium cannabis lifestyle brand DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) this morning announced the closing of its previously outlined non-brokered private placement of subscription receipts, whereby Aphria Inc. (TSX: APH) (OTC: APHQF) and Koicha Partners LP acquired from DOJA an aggregate of roughly nine million subscription receipts at a price per unit of $1.39, generating gross proceeds of $12.5 million. Per the update, this financing is intended to support the strategic positioning of Hiku Brands Company Ltd., the anticipated combined company resulting from the merger of DOJA and Tokyo Smoke. “We're thrilled to have strategic partners in Aphria…

Continue Reading

TuesdayJan 09, 2018 10:08 am

CannabisNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Responds to Cole Memo Repeal

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning issued a follow-up statement to the memorandum issued by Attorney General Jeff Sessions on January 4, 2018, concerning marijuana enforcement and the repeal of the Cole Memo. In the update, Veritas noted that the AG’s decision largely relates to the recreational cannabis marketplace, in which individual states have allowed sales over the last 24 months. Conversely, the company notes, it does not affect the medical cannabis marketplace. As such, Veritas intends to build on its commitment to advancing the science of medical cannabis…

Continue Reading